Windward Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-46,283
| Closed | -$3.33M | – | 79 |
|
|
2022
Q4 | $3.33M | Sell |
46,283
-141
| -0.3% | -$10.6K | 0.36% | 51 |
|
|
2022
Q3 | $3.3M | Buy |
46,424
+317
| +0.7% | +$23K | 0.37% | 48 |
|
|
2022
Q2 | $3.55M | Buy |
46,107
+273
| +0.6% | +$20.8K | 0.38% | 49 |
|
|
2022
Q1 | $3.35M | Sell |
45,834
-533
| -1% | -$35.8K | 0.3% | 54 |
|
|
2021
Q4 | $2.89M | Buy |
46,367
+587
| +1% | +$34.4K | 0.24% | 60 |
|
|
2021
Q3 | $2.71M | Buy |
45,780
+187
| +0.4% | +$12.3K | 0.25% | 60 |
|
|
2021
Q2 | $3.05M | Buy |
45,593
+302
| +0.7% | +$19.7K | 0.28% | 57 |
|
|
2021
Q1 | $2.86M | Sell |
45,291
-175
| -0.4% | -$10.9K | 0.29% | 59 |
|
|
2020
Q4 | $2.82M | Sell |
45,466
-60
| -0.1% | -$3.69K | 0.28% | 59 |
|
|
2020
Q3 | $2.75M | Buy |
45,526
+317
| +0.7% | +$19.1K | 0.28% | 54 |
|
|
2020
Q2 | $2.66M | Sell |
45,209
-973
| -2% | -$58.2K | 0.3% | 52 |
|
|
2020
Q1 | $2.57M | Sell |
46,182
-5,979
| -11% | -$365K | 0.34% | 50 |
|
|
2019
Q4 | $3.35M | Buy |
52,161
+9,356
| +22% | +$536K | 0.36% | 56 |
|
|
2019
Q3 | $2.17M | Buy |
42,805
+4,531
| +12% | +$213K | 0.26% | 60 |
|
|
2019
Q2 | $1.74M | Buy |
38,274
+414
| +1% | +$19.3K | 0.22% | 60 |
|
|
2019
Q1 | $1.81M | Buy |
37,860
+1,396
| +4% | +$69.5K | 0.23% | 59 |
|
|
2018
Q4 | $1.9M | Buy |
36,464
+1,661
| +5% | +$89.2K | 0.27% | 55 |
|
|
2018
Q3 | $2.16M | Buy |
34,803
+792
| +2% | +$47K | 0.27% | 51 |
|
|
2018
Q2 | $1.88M | Buy |
34,011
+411
| +1% | +$22.2K | 0.27% | 62 |
|
|
2018
Q1 | $2.13M | Buy |
33,600
+6,099
| +22% | +$392K | 0.31% | 48 |
|
|
2017
Q4 | $1.69M | Buy |
27,501
+13,281
| +93% | +$831K | 0.25% | 51 |
|
|
2017
Q3 | $906K | Buy |
14,220
+494
| +4% | +$28.8K | 0.15% | 52 |
|
|
2017
Q2 | $765K | Buy |
13,726
+1,984
| +17% | +$108K | 0.13% | 64 |
|
|
2017
Q1 | $639K | Sell |
11,742
-9,394
| -44% | -$515K | 0.11% | 64 |
|
|
2016
Q4 | $1.24M | Buy |
21,136
+2,210
| +12% | +$121K | 0.24% | 45 |
|
|
2016
Q3 | $1.02M | Buy |
18,926
+3,286
| +21% | +$211K | 0.19% | 45 |
|
|
2016
Q2 | $1.15M | Buy |
15,640
+106
| +0.7% | +$7.49K | 0.22% | 45 |
|
|
2016
Q1 | $992K | Buy |
15,534
+258
| +2% | +$16.3K | 0.19% | 45 |
|
|
2015
Q4 | $1.05M | Sell |
15,276
-29
| -0.2% | -$1.92K | 0.21% | 44 |
|
|
2015
Q3 | $906K | Buy |
15,305
+4,299
| +39% | +$273K | 0.25% | 45 |
|
|
2015
Q2 | $732K | Sell |
11,006
-960
| -8% | -$63.3K | 0.2% | 49 |
|
|
2015
Q1 | $772K | Buy |
11,966
+741
| +7% | +$46.4K | 0.2% | 49 |
|
|
2014
Q4 | $663K | Buy |
11,225
+1,014
| +10% | +$57.2K | 0.19% | 50 |
|
|
2014
Q3 | $523K | Sell |
10,211
-17
| -0.2% | -$849 | 0.17% | 52 |
|
|
2014
Q2 | $496K | Buy |
10,228
+506
| +5% | +$24.9K | 0.17% | 54 |
|
|
2014
Q1 | $505K | Sell |
9,722
-16
| -0.2% | -$851 | 0.18% | 51 |
|
|
2013
Q4 | $518K | Sell |
9,738
-45
| -0.5% | -$2.29K | 0.18% | 49 |
|
|
2013
Q3 | $453K | Sell |
9,783
-8,300
| -46% | -$364K | 0.18% | 48 |
|
|
2013
Q2 | $808K | Buy |
+18,083
| New | +$785K | 0.31% | 45 |
|
Other funds holding BMY
Windward Capital Management's BMY Position: Q1 2023 in Review
Windward Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 46,283 shares — an estimated $3.33M sold.
Windward Capital Management first reported a position in BMY in Q2 2013 and held it in 39 quarters. The position peaked at $3.55M in Q2 2022. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.
- Windward Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
- Windward Capital Management sold 46,283 Bristol-Myers Squibb shares in Q1 2023, an estimated $3.33M.
- Windward Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 39 quarters.
- Windward Capital Management's Bristol-Myers Squibb position peaked at $3.55M in Q2 2022.
- 2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.
Based on Windward Capital Management's 13F filing for Q1 2023, filed 24 Apr 2023.